Brain Care Score and Neuroimaging Markers of Brain Health in Asymptomatic Middle-Age Persons.
Rivier CA., Singh S., Senff J., Tack RW., Marini S., Clocchiatti-Tuozzo S., Huo S., Renedo D., Papier K., Conroy M., Littlejohns TJ., Chemali Z., Kourkoulis C., Payabvash S., Newhouse A., Westover MB., Lazar RM., Pikula A., Ibrahim S., Howard VJ., Howard G., Brouwers HB., Van Duijn CM., Fricchione G., Tanzi RE., Yechoor N., Sheth KN., Anderson CD., Rosand J., Falcone GJ.
ObjectivesTo investigate associations between health-related behaviors as measured using the Brain Care Score (BCS) and neuroimaging markers of white matter injury.MethodsThis prospective cohort study in the UK Biobank assessed the BCS, a novel tool designed to empower patients to address 12 dementia and stroke risk factors. The BCS ranges from 0 to 21, with higher scores suggesting better brain care. Outcomes included white matter hyperintensities (WMH) volume, fractional anisotropy (FA), and mean diffusivity (MD) obtained during 2 imaging assessments, as well as their progression between assessments, using multivariable linear regression adjusted for age and sex.ResultsWe included 34,509 participants (average age 55 years, 53% female) with no stroke or dementia history. At first and repeat imaging assessments, every 5-point increase in baseline BCS was linked to significantly lower WMH volumes (25% 95% CI [23%-27%] first, 33% [27%-39%] repeat) and higher FA (18% [16%-20%] first, 22% [15%-28%] repeat), with a decrease in MD (9% [7%-11%] first, 10% [4%-16%] repeat). In addition, a higher baseline BCS was associated with a 10% [3%-17%] reduction in WMH progression and FA decline over time.DiscussionThis study extends the impact of the BCS to neuroimaging markers of clinically silent cerebrovascular disease. Our results suggest that improving one's BCS could be a valuable intervention to prevent early brain health decline.